The global sterile tubing welder market size is expected to reach USD 3.46 billion by 2030, registering a CAGR of 5.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing demand for blood, blood products, and biopharmaceutical products is anticipated to drive the market for sterile tubing welder.
Blood transfusion is one of the frequently performed medical procedures. Severe road traffic injuries, major surgical procedures, and hematology diseases, such as thalassemia, anemia, and leukemia, are some of the key reasons for the transfusion procedure. According to the Association for Safe International Road Travel (ASIRT) article, nearly 20 to 50 million individuals are injured or disabled in road accidents. Thus, high cases of road traffic injuries are anticipated to fuel sterile tubing welder market growth.
Wastage of collected blood due to contamination, blood bag leakages, improper storage, and lack of proper handling facilities and qualified professionals are anticipated to increase the demand for innovative and medically advanced sterile instruments, such as automated sterile tubing welders. For instance, in India, nearly 10% of blood components and around 71% of whole blood are wasted each year due to the above-stated reasons.
Request a free sample copy or view report summary: Sterile Tubing Welder Market Report
Based on mode, the automatic segment held the largest market share of over 80% in 2022and is anticipated to witness the highest growth over the forecast period due to ease of operation and reduced labor costs
On the basis of application, the blood processing segment held the largest revenue share of over 60% in 2022 due to a large number of patients being treated using apheresis annually across the globe
By end-use, the hospitals segment accounted for the largest revenue share of over 40% in 2022 owing to rise in the adoption of advanced instruments and enhanced services in these settings
North America dominated the market and accounted for the largest revenue share of over 35% in 2022. This can be attributed to the presence of numerous biopharmaceutical companies and high demand for biopharmaceutical products
The Asia Pacific region is expected to grow at the fastest CAGR of 5.8% during the forecast period due to a large number of clinical trials being conducted and rise in the number of medical device companies in the region
Mergers & acquisitions are the key strategies adopted by the market players
Grand View Research has segmented the global sterile tubing welder market on the basis of on application, mode, end-use, and region:
Sterile Tubing Welder Application Outlook (Revenue, USD Million, 2018 - 2030)
Biopharmaceutical
Blood Processing
Diagnostic Laboratories
Others
Sterile Tubing Welder Mode Outlook (Revenue, USD Million, 2018 - 2030)
Manual
Automatic
Sterile Tubing Welder End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Research Clinics
Blood Centers
Others
Sterile Tubing Welder Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Players in the Sterile Tubing Welder Market
Sartorius AG
Terumo BCT, Inc.
GE Healthcare
MGA Technologies
Vante Biopharm / Sebra.
Genesis BPS
Biomen Biosystems Co., Ltd.
SynGen, Inc.
Sentinel Process Systems, Inc.
Flex Concepts, Inc.
Shanghai Le Pure Biological Technology Co., Ltd.
"The quality of research they have done for us has been excellent..."